{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T19:40:01Z","timestamp":1745955601773,"version":"3.40.4"},"reference-count":33,"publisher":"Institute of Biochemistry","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BIOMED KHIM"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:p>The brain's nucleus accumbens (NAc) is a key link in the internal reinforcement system, which mediates manifestations of various components of addiction, including ethanol. The neuroinflammatory theory of alcoholism development suggests that changes in the molecular mechanisms of the innate immune system may be involved in the development of this pathology. The aim of our study was to investigate the effect of azithromycin (AZM) on expression of toll-like receptor system genes in the NAc during experimental alcoholization of rats. The objectives of the study also included an in silico search for possible molecular targets for AZM that could be associated with the toll-like receptor system. AZM corrected the changes observed in the expression of toll-like receptor system genes under conditions of alcohol withdrawal after long-term ethanol exposure in the NAc of the brain. The in silico analysis revealed the most probable proteins which could be involved in the interaction with AZM. Based on results of these predictions a number of assumptions about possible ways of implementing the observed pharmacological effect of AZM in the experiment have been made.<\/jats:p>","DOI":"10.18097\/pbmcr1523","type":"journal-article","created":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T13:25:00Z","timestamp":1742822700000},"page":"95-102","source":"Crossref","is-referenced-by-count":0,"title":["The study of the azithromycin effect on gene expression of the toll-like receptor system in the brain nucleus accumbens of rats during ethanol withdrawal and search for possible molecular targets by an in silico method"],"prefix":"10.18097","volume":"71","author":[{"given":"M.I.","family":"Airapetov","sequence":"first","affiliation":[{"name":"Institute of Experimental Medicine, St. Petersburg, Russia; S.M. Kirov Military Medical Academy, St. Petersburg, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.O.","family":"Eresko","sequence":"additional","affiliation":[{"name":"Institute of Experimental Medicine, St. Petersburg, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.A.","family":"Shchukina","sequence":"additional","affiliation":[{"name":"Institute of Experimental Medicine, St. Petersburg, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.M.","family":"Matveev","sequence":"additional","affiliation":[{"name":"Institute of Experimental Medicine, St. Petersburg, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Andreev","sequence":"additional","affiliation":[{"name":"Institute of Experimental Medicine, St. Petersburg, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.R.","family":"Bychkov","sequence":"additional","affiliation":[{"name":"Institute of Experimental Medicine, St. Petersburg, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.A.","family":"Lebedev","sequence":"additional","affiliation":[{"name":"Institute of Experimental Medicine, St. Petersburg, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.D.","family":"Shabanov","sequence":"additional","affiliation":[{"name":"Institute of Experimental Medicine, St. Petersburg, Russia; S.M. Kirov Military Medical Academy, St. Petersburg, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7443","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref1","unstructured":"Shabanov P.D., Lebedev A.A., Meshcherov Sh.K. (2002) In: Dopamine and Reinforcing Systems of the Brain. Lan', S-Pb, 208 p."},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Becker H.C., Mulholland P.J. (2014) Neurochemical mechanisms of alcohol withdrawal. Handb. Clin. Neurol., 125, 133\u2013156.","DOI":"10.1016\/B978-0-444-62619-6.00009-4"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Xu Y., Lin Y., Yu M., Zhou K. (2024) The nucleus accumbens in reward and aversion processing: insights and implications. Front. Behav. Neurosci., 18, 1420028.","DOI":"10.3389\/fnbeh.2024.1420028"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Yan H., Shlobin N.A., Jung Y., Zhang K.K., Warsi N., Kulkarni A.V., Ibrahim G.M. (2022) Nucleus accumbens: a systematic review of neural circuitry and clinical studies in healthy and pathological states. J. Neurosurg., 138(2), 337\u2013346.","DOI":"10.3171\/2022.5.JNS212548"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"L\u00f3pez-Gambero A.J., Rodr\u00edguez de Fonseca F., Su\u00e1rez J. (2021) Energy sensors in drug addiction: a potential therapeutic target. Addict. Biol., 26(2), e12936.","DOI":"10.1111\/adb.12936"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Dahchour A., Ward R.J. (2022) Changes in brain dopamine extracellular concentration after ethanol administration; rat microdialysis studies. Alcohol Alcohol., 57(2), 165\u2013175.","DOI":"10.1093\/alcalc\/agab072"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Airapetov M., Eresko S., Lebedev A., Bychkov E., Shabanov P. (2021) The role of Toll-like receptors in neurobiology of alcoholism. Biosci. Trends, 15(2), 74\u201382.","DOI":"10.5582\/bst.2021.01041"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Crews F.T., Coleman L.G. Jr., Macht V.A., Vetreno R.P. (2024) Alcohol, HMGB1, and innate immune signaling in the brain. Alcohol Res., 44(1), 4.","DOI":"10.35946\/arcr.v44.1.04"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Sullivan E.V., Deshmukh A., de Rosa E., Rosenbloom M.J., Pfefferbaum A. (2005) Striatal and forebrain nuclei volumes: contribution to motor function and working memory deficits in alcoholism. Biol. Psychiatry, 57(7), 768\u2013776.","DOI":"10.1016\/j.biopsych.2004.12.012"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Airapetov M., Eresko S., Ignatova P., Lebedev A., Bychkov E., Shabanov P. (2024) Effect of rifampicin on TLR4-signaling pathways in the nucleus accumbens of the rat brain during abstinence of long-term alcohol treatment. Alcohol Alcohol., 59(3), agae016.","DOI":"10.1093\/alcalc\/agae016"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Kopper T.J., Gensel J.C. (2021) Continued development of azithromycin as a neuroprotective therapeutic for the treatment of spinal cord injury and other neurological conditions. Neural. Regen. Res., 16(3), 508\u2013509.","DOI":"10.4103\/1673-5374.293146"},{"key":"ref12","unstructured":"Paxinos G., Watson C. (2017) In: The Rat Brain in Stereotaxic Coordinates. Academic Press, 160 p."},{"key":"ref13","unstructured":"Way2Drug. Understanding Chemical-Biological Interactions. Predictive services. Retrieved October 14, 2024, from: https:\/\/www.way2drug.com\/dr\/."},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Crews F.T., Zou J., Qin L. (2011) Induction of innate immune genes in brain create the neurobiology of addiction. Brain Behav. Immun., 25(1), 4\u201312.","DOI":"10.1016\/j.bbi.2011.03.003"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Crews F.T., Vetreno R.P. (2016) Mechanisms of neuroimmune gene induction in alcoholism. Psychopharmacology, 233(9), 1543\u20131557.","DOI":"10.1007\/s00213-015-3906-1"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Coleman L.G. Jr., Zou J., Qin L., Crews F.T. (2018) HMGB1\/IL-1\u03b2 complexes regulate neuroimmune responses in alcoholism, Brain Behav. Immun., 72, 61\u201377.","DOI":"10.1016\/j.bbi.2017.10.027"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Zhang B., Bailey W.M., Kopper T.J., Orr M.B., Feola D.J., Gensel J.C. (2015) Azithromycin drives alternative macrophage activation and improves recovery and tissue sparing in contusion spinal cord injury. J. Neuroinflammation, 12, 218.","DOI":"10.1186\/s12974-015-0440-3"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Gensel J.C., Kopper T.J., Zhang B., Orr M.B., Bailey W.M. (2017) Predictive screening of M1 and M2 macrophages reveals the immunomodulatory effectiveness of post spinal cord injury azithromycin treatment. Sci. Rep., 7, 40144.","DOI":"10.1038\/srep40144"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Kopper T.J., McFarlane K.E., Bailey W.M., Orr M.B., Zhang B., Gensel J.C. (2019) Delayed azithromycin treatment improves recovery after mouse spinal cord injury. Front. Cell. Neurosci., 13, 490.","DOI":"10.3389\/fncel.2019.00490"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Amantea D., Certo M., Petrelli F., Bagetta G. (2016) Neuroprotective properties of a macrolide antibiotic in a mouse model of middle cerebral artery occlusion: characterization of the immunomodulatory effects and validation of the efficacy of intravenous administration. Assay Drug Dev. Technol., 14(5), 298\u2013307.","DOI":"10.1089\/adt.2016.728"},{"key":"ref21","unstructured":"Varano G.P., Parisi V., Adornetto A., Cavaliere F., Amantea D., Nucci C., Corasaniti M.T., Morrone L.A., Bagetta G., Russo R. (2017) Post-ischemic treatment with azithromycin protects ganglion cells against retinal ischemia\/reperfusion injury in the rat. Molecular Vision, 23, 911\u2013921."},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Amantea D., Petrelli F., Greco R., Tassorelli C., Corasaniti M.T., Tonin P., Bagetta G. (2019) Azithromycin affords neuroprotection in rat undergone transient focal cerebral ischemia. Front. Neurosci., 13, 1256.","DOI":"10.3389\/fnins.2019.01256"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Wu S., Tian X., Mao Q., Peng C. (2023) Azithromycin attenuates wheezing after pulmonary inflammation through inhibiting histone H3K27me3 hypermethylation mediated by EZH2. Clin. Epigenetics, 15, 12.","DOI":"10.1186\/s13148-023-01430-y"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Tarassishin L., Suh H.-S., Lee S.C. (2011) Interferon regulatory factor 3 plays an anti-inflammatory role in microglia by activating the PI3K\/Akt pathway. J. Neuroinflammation, 8, 187.","DOI":"10.1186\/1742-2094-8-187"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Salvador R., Aridgides D., PereiraPerrin M. (2014) Parasite-derived neurotrophic factor\/trans-sialidase of Trypanosoma cruzi links neurotrophic signaling to cardiac innate immune response. Infect. Immun., 82(9), 3687\u20133696.","DOI":"10.1128\/IAI.02098-14"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Thiel F.G., Asgarbeik S., Glaubitz J. (2023) IRAK3-mediated suppression of pro-inflammatory MyD88\/IRAK signaling affects disease severity in acute pancreatitis. Sci. Rep., 13, 10833.","DOI":"10.1038\/s41598-023-37930-3"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Kaur N., Ruiz-Velasco A., Raja R., Howell G., Miller J.M., Abouleisa R.R.E., Ou Q., Mace K., Hille S.S., Frey N., Binder P., Smith C.P., Fachim H., Soran H., Swanton E., Mohamed T.M.A., M\u00fcller O.J., Wang X., Chernoff J., Cartwright E.J., Liu W. (2022) Paracrine signal emanating from stressed cardiomyocytes aggravates inflammatory microenvironment in diabetic cardiomyopathy. iScience, 25(3), 103973.","DOI":"10.1016\/j.isci.2022.103973"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Xing J., Xu H., Liu C., Wei Z., Wang Z., Zhao L., Ren L. (2019) Melatonin ameliorates endoplasmic reticulum stress in N2a neuroblastoma cell hypoxia-reoxygenation injury by activating the AMPK-Pak2 pathway. Cell Stress Chaperones, 24(3), 621\u2013633.","DOI":"10.1007\/s12192-019-00994-0"},{"key":"ref29","unstructured":"Lebedev K.A., Ponyakina I.D. (2017) In: Immunology of Image-Recognizing Receptors. Lenand, Moscow, 256 p."},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Lin S.J., Kuo M.L., Hsiao H.S., Lee P.T. (2016) Azithromycin modulates immune response of human monocyte-derived dendritic cells and CD4+ T cells. Int. Immunopharmacol., 40, 318\u2013326.","DOI":"10.1016\/j.intimp.2016.09.012"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Stellari F.F., Sala A., Donofrio G. (2014) Azithromycin inhibits nuclear factor-\u03baB activation during lung inflammation: an in vivo imaging study. Pharmacol. Res. Perspect., 2(5), e00058.","DOI":"10.1002\/prp2.58"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Cigana C., Assael B.M., Melotti P. (2007) Azithromycin selectively reduces tumor necrosis factor alpha levels in cystic fibrosis airway epithelial cells. Antimicrob. Agents Chemother., 51(3), 975\u2013981.","DOI":"10.1128\/AAC.01142-06"},{"key":"ref33","unstructured":"The Human Protein Atlas. Predictive services. Retrieved October 14, 2024, from: https:\/\/www.proteinatlas.org\/."}],"container-title":["Biomeditsinskaya Khimiya"],"original-title":[],"language":"ru","deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T18:58:45Z","timestamp":1745953125000},"score":1,"resource":{"primary":{"URL":"http:\/\/pbmc.ibmc.msk.ru\/en\/article-en\/PBMC-2025-71-2-95"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025]]},"published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.18097\/pbmcr1523","relation":{},"ISSN":["2310-6905","2310-6972"],"issn-type":[{"type":"electronic","value":"2310-6905"},{"type":"print","value":"2310-6972"}],"subject":[],"published":{"date-parts":[[2025]]}}}